Development and validation of an analytical method for regorafenib and its metabolites in mouse plasma
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference28 articles.
1. Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial;Cheng;J. Clin. Oncol.,2013
2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-con-trolled trial;Cheng;Lancet Oncol.,2009
3. Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinibin patients with metastatic renal cell carcinoma;Hutson;J. Clin. Oncol.,2014
4. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Grothey;Lancet,2013
5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetic interaction between regorafenib and atorvastatin in rats;Pharmacological Reports;2024-04-18
2. A new validated high‐performance liquid chromatography method for the determination of regorafenib in rat plasma: Application for pharmacokinetic study;SEPARATION SCIENCE PLUS;2024-03-10
3. Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography‐tandem mass spectrometry;Journal of Separation Science;2024-03
4. Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors;Computers in Biology and Medicine;2024-01
5. Development and evaluation of regorafenib loaded liquid suppository for rectal delivery: In vitro, in vivo analyses;Journal of Drug Delivery Science and Technology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3